Aerie Pharmaceuticals (AERI) Debt/EBITDA US GAAP (year values)

2017 2018 2019 2020 2021   LTM ?
Debt/EBITDA 0.88 0.89 0.69 0.21 -15.5   -53.5
Changes by years, y/y, % -23% +1% -22% -69% -7 333%    

Aerie Pharmaceuticals. Debt/EBITDA

Aerie Pharmaceuticals. Debt/EBITDA, changes, %

Aerie Pharmaceuticals (AERI) Debt/EBITDA US GAAP (quarter values)

2021Q3 2021Q4 2022Q1 2022Q2 2022Q3   LTM ?
Debt/EBITDA -0.90 -15.5 -12.2 -38.2 -53.5   -53.5
Changes by years, y/y, % -1 478% -7 387% +6 016% +7 728% +5 814%    
Changes by quarters, q/q, % +86% +1 609% -21% +213% +40%    

Aerie Pharmaceuticals. Debt/EBITDA

Aerie Pharmaceuticals. Debt/EBITDA, changes, y/y, %

Aerie Pharmaceuticals. Debt/EBITDA, changes, q/q, %